The renal bone diseases in children treated with dialysis

Advances in Renal Replacement Therapy

Volumn 3, Issue 1, 1996, Pages 14-23

  Sanchez, C P ^a   Salusky, I B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bone; children; dialysis; renal failure; renal osteodystrophy

Indexed keywords

BONE DISEASE; BONE TURNOVER; CHILD; DIALYSIS; HUMAN; HYPERPHOSPHATEMIA; HYPOCALCEMIA; KIDNEY FAILURE; OSTEITIS FIBROSA; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; REVIEW; SECONDARY HYPERPARATHYROIDISM;

EID: 0030033275     PISSN: 10734449     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1073-4449(96)80037-9     Document Type: Article

References (78)

1. HH Malluche MC Faugere Risk of adynamic bone disease in dialyzed patients Kidney Int 42 suppl 38 1992 62 67
2. R Mathias IB Salusky W Harmon Renal bone disease in pediatric and young adult patients on hemodialysis in a children's hospital J Am Soc Nephrol 3 1993 1938 1946
3. E Slatopolsky JA Delmez Pathogenesis of secondary hyperparathyroidism Am J Kidney Dis 23 1994 229 236
4. P Urena M Kubrusly M Mannstadt The renal PTH/PTHrP receptor is down-regulated in rats with chronic renal failure Kidney Int 45 1994 605 611
5. N Fukuda H Tanaka Y Tominaga Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients J Clin Invest 92 1993 1436 1443
6. E Reiss MJ Canterbury MA Bercovitz The role of phosphate in the secretion of parathyroid hormone in man J Clin Invest 49 1970 2146 2149
7. S Lopez-Hilker AS Dusso NS Rapp Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol Am J Physiol 259 1990 432 437
8. A Fine D Cox B Fontaine Elevation of serum phosphate affects parathyroid hormone levels in only 50% of hemodialysis patients, which is unrelated to changes in serum calcium J Am Soc Nephrol 3 1993 1947 1953
9. H Yi M Fukagawa H Yamato Prevention of enhanced parathyroid hormone secretion, synthesis and hyperplasia by mild dietary phosphorus restriction in early chronic renal failure in rats: Possible direct role of phosphorus Nephron 70 1995 242 248
10. AK Cheung SC Manolagas BD Catherwood Determinants of serum 1,25-dihydroxyvitamin D3 levels in renal disease Kidney Int 24 1983 104 109
11. AA Portale BE Boothe HC Tsai Reduced plasma concentration of 1,25-dihydroxyvitamin D3 in children with moderate renal insufficiency Kidney Int 21 1982 627 633
12. 3 of transcription of the pre-proparathyroid hormone gene Endocrinology 119 1986 2864 2866
13. T Naveh-Many J Silver Regulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia and vitamin D in the rat J Clin Invest 86 1990 1313 1319
14. 3 inhibits parathyroid cell proliferation in experimental uremia Kidney Int 35 1989 1049 1056
15. EM Brown RE Wilson RC Eastman Abnormal regulation of parathyroid hormone release by calcium in secondary hyperparathyroidism due to chronic renal failure J Clin Endocrinol Metab 54 1982 172 179
16. AJ Felsenfeld M Rodriguez R Dunlay A comparison of parathyroid-gland function in hemodialysis patients with different forms of renal osteodystrophy Nephrol Dial Transplant 6 1991 244 251
17. 3 J Clin Invest 83 1989 1349 1355
18. G Cannella E Bonucci D Rolla Evidence of healing of secondary hyperparathyroidism in chronically hemodialyzed uremic patients treated with longterm calcitriol Kidney Int 46 1994 1124 1132
19. 2+-sensing receptor Am J Kidney Dis 25 1995 506 513
20. 3 Endocrinology 136 1995 499 504
21. EM Brown Four-parameter model of the sigmoidal relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue J Clin Endocrinol Metab 56 1983 572 581
22. JA Ramirez WG Goodman J Gornbein Direct in vivo comparison of calcium-regulated parathyroid hormone secretion in normal volunteers and patients with secondary hyperparathyroidism J Clin Endocrinol Metab 76 1993 1489 1494
23. JA Ramirez WG Goodman TR Belin Calcitriol therapy and calcium-regulated PTH secretion in patients with secondary hyperparathyroidism Am J Physiol 267 1994 961 967
24. P Messa C Vallone G Mioni Direct in vivo assessment of parathyroid hormone-calcium relationship curve in renal patients Kidney Int 46 1994 1713 1720
25. M Kitaoka M Fukagawa E Ogata Reduction of functioning parathyroid cell mass by ethanol injection in chronic dialysis patients Kidney Int 46 1994 1110 1117
26. A Arnold MF Brown P Urena Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia J Clin Invest 95 1995 2047 2053
27. JC Rodriguez-Perez C Plaza A Torres Low turnover bone disease is the more common form of bone disease in CAPD patients Adv Peritoneal Dial 8 1992 376 380
28. PJ Marie A Lomri C Vernejoul Relationships between histomorphometric features of bone formation and bone cell characteristics in vitro in renal osteosdystrophy J Clin Endocrinol Metab 69 1989 1166 1173
29. AJ Hutchison RW Whitehouse AJ Freemont Histological radiological and biochemical features of adynamic bone lesion in continuous ambulatory peritoneal dialysis patients Am J Nephrol 14 1994 19 29
30. CP Sanchez WG Goodman JA Ramirez Calciumregulated parathyroid hormone secretion in adynamic renal osteodystrophy Kidney Int 48 1995 838 843
31. F Llach S Massry FR Singer Skeletal resistance of endogenous parathyroid hormone in patients with early renal failure: A possible cause of secondary hyperparathyroidism J Clin Endocrinol Metab 41 1975 339 345
32. T Galceran KJ Martin JJ Morrissey Role of 1,25-dihydroxyvitamin D on the skeletal resistance to parathyroid hormone Kidney Int 32 1987 801 807
33. IB Salusky JW Coburn J Brill Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD Kidney Int 33 1988 975 982
34. DJ Sherrard DJ Baylink JE Wergedal Quantitative histological studies on the pathogenesis of uremic bone disease J Clin Endocrinol Metab 39 1974 119 135
35. IB Salusky JA Ramirez W Oppenheim Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD Kidney Int 45 1994 253 258
36. DL Andress DB Endres SM Ott Aluminum associated bone disease in chronic renal failure: High prevalence in a long-term dialysis population J Bone Miner Res 1 1986 391 398
37. ME Cohen-Solal JL Sebert Boudailliez Nonaluminic bone disease in non-dialyzed uremic patients: A new type of osteopathy due to overtreatment? Bone 13 1992 1 5
38. DJ Sherrard G Hercz Y Pei The spectrum of bone disease in end-stage renal failure: An evolving disorder Kidney Int 43 1993 436 442
39. D Hernandez MT Concepcion V Lorenzo Adynamic bone disease with negative aluminum staining in predialysis patients: Prevalence and evolution after maintenance dialysis Nephrol Dial Transplant 9 1994 517 523
40. WG Goodman JA Ramirez TR Belin Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy Kidney Int 46 1994 1160 1166
41. G Hercz DJ Sherrard W Chan Renal osteodystrophy: Follow-up after 5 years J Am Soc Nephrol 5 1994 851
42. G Hercz Y Pei Greenwood Aplastic osteodystrophy without aluminum: The role of “suppressed” parathyroid function Kidney Int 44 1993 860 866
43. P Kurz MC Moniere-Faugere B Bognar Evidence for abnormal calcium homeostasis in patients with adynamic bone disease Kidney Int 46 1994 855 861
44. SM Genunth L Klein S Rabinovich Osteomalacia accompanying chronic anticonvulsant therapy J Clin Endocrinol Metab 35 1972 378 386
45. 3 levels in patients receiving anticonvulsant drugs J Clin Endocrinol Metab 44 1977 617 621
46. DJ Sherrard Renal osteodystrophy Semin Nephrol 6 1986 56 67
47. IB Salusky JA Ramirez WG Goodman Recent advances in the management of renal osteodystrophy in children Curr Opin Nephrol Hypertens 2 1993 580
48. O Mehls Renal osteodystrophy in children: Etiology and clinical aspects RN Fine AB Gruskin Endstage Renal Disease in Children 1984 Saunders Philadelphia, PA
49. IB Salusky J Brill W Oppenheim Features of renal osteodystrophy in pediatric patients receiving regular peritoneal dialysis Semin Nephrol 9 1989 37 42
50. RM Gipstein JW Coburn JA Adams Calciphylaxis in man: A syndrome of tissue necrosis and vascular calcification in 11 patients with chronic renal failure Arch Intern Med 136 1976 1273 1280
51. AC Alfrey CC Solomons J Ciricillo Extraosseous calcification: Evidence for abnormal pyrophosphate metabolism in uremia J Clin Invest 57 1976 692 699
52. CE Cann Quantitative CT for determination of bone mineral density: A review Radiology 166 1988 509
53. IB Salusky WG Goodman Growth hormone and calcitriol as modifiers of bone formation in renal osteodystrophy Kidney Int 48 1995 657 665
54. P Joffe JG Heaf L Hyldstrup Osteocalcin: A noninvasive index of metabolic bone disease in patients treated by CAPD Kidney Int 46 1994 838 846
55. ME Cohen-Solal JL Sebert B Boudailliez Comparison of intact, midregion and carboxyterminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients J Clin Endocrinol Metab 73 1991 516 524
56. DL Andress DB Endres SM Ott Parathyroid hormone in aluminum bone disease: A comparison of parathyroid hormone assays Kidney Int 29 1986 S87 S90
57. WG Goodman IB Salusky Evolution of secondary hyperparathyroidism during oral calcitriol therapy in pediatric renal osteodystrophy Contrib Nephrol 90 1991 189 195
58. E Nathan SE Pederson Dialysis encephalopathy in a non-dialyzed uremic boy treated with aluminum hydroxide orally Acta Paediatr Scand 69 suppl 18 1980 793 796
59. AM Pierides WG Edwards US Cullu Hemodialysis encephalopathy with osteomalacic fractures and muscle weakness Kidney Int 18 1980 115 124
60. S Pflanz IS Henderson N McElduff Calcium acetate versus calcium carbonate as phosphatebinding agents in chronic hemodialysis Nephrol Dial Transplant 9 1994 1121 1124
61. K Schaefer J Scheer G Asmus The treatment of uremic hyperphosphatemia with calcium acetate and calcium carbonate: A comparative study Nephrol Dial Transplant 6 1991 171 175
62. ML Mai M Emmett MS Sheikh Calcium acetate: An effective phosphorus binder in patients with renal failure Kidney Int 36 1989 690 695
63. MS Sheikh JA Maguire M Emmett Reduction of dietary phosphorus absorption by phosphorus binders: A theoretical, in vitro, and in vivo study J Clin Invest 83 1989 66 73
64. Y Tsukamoto R Moriya Y Nagaba Effect of administering calcium carbonate to treat secondary hyperparathyroidism in nondialyzed patients with chronic renal failure Am J Kidney Dis 25 1995 879 886
65. T Weinreich J Passlick-Deetjen E Ritz Low dialysate calcium in continuous ambulatory peritoneal dialysis: A randomized controlled multicenter trial Am J Kidney Dis 25 1995 452 460
66. IB Salusky J Foley P Nelson Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease N Engl J Med 324 1991 527 531
67. BA Molitoris DH Froment TA Mackenzie Citrate: A major factor in the toxicity of orally administered aluminum compounds Kidney Int 36 1989 949 953
68. E Slatopolsky M Berkoben J Kelber Effects of calcitriol and non-calcemic vitamin D analogs on secondary hyperparathyroidism Kidney Int 42 suppl 38 1992 43 49
69. E Slatopolsky C Weerts J Thielan Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydrocholecalciferol in uremic patients J Clin Invest 74 1984 2136 2143
70. JA Delmez CS Dougan BK Gearing The effects of intraperitoneal calcitriol on calcium and parathyroid hormone Kidney Int 31 1987 795 799
71. 3 pulse therapy N Engl J Med 315 1990 421
72. 3 in experimental renal hyperparathyroidism Kidney Int 44 1993 1259 1265
73. S Mazzaferro M Pasquali P Ballanti Intravenous versus oral calcitriol therapy in renal osteodystrophy: Results of a prospective, pulsed and dosecomparable study Miner Electrolyte Metab 20 1994 122 129
74. AJ Brown CR Ritter JL Finch The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion J Clin Invest 84 1989 728 732
75. LD Quarles B Lobaugh G Murphy Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia J Clin Endocrinol Metab 75 1992 145 150
76. M Fukagawa M Kitaoka H Yi Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients Nephron 68 1994 221 228
77. M Kaye L Rosenthal RO Hill Long-term outcome following total parathyroidectomy in patients with end-stage renal disease Clin Nephrol 39 1993 192 197
78. A Falchetti AE Bale A Amorosi Progression of uremic hyperparathyroidism involves allelic loss on chromosome II J Clin Endocrinol Metab 76 1993 139 144